Literature DB >> 30416817

Hemorrhage of a pancreatic metastasis from lung adenocarcinoma after osimertinib therapy.

Kazuki Hayasaka1, Satoshi Shiono1, Naoki Yanagawa2, Kei Yarimizu1, Katsuyuki Suzuki1, Makoto Endoh1.   

Abstract

Entities:  

Year:  2018        PMID： 30416817      PMCID： PMC6196163          DOI： 10.21037/jtd.2018.08.108

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  16 in total

1.  A method of high-throughput functional evaluation of EGFR gene variants of unknown significance in cancer.

Authors:  Shinji Kohsaka; Masaaki Nagano; Toshihide Ueno; Yoshiyuki Suehara; Takuo Hayashi; Naoko Shimada; Kazuhisa Takahashi; Kenji Suzuki; Kazuya Takamochi; Fumiyuki Takahashi; Hiroyuki Mano
Journal:  Sci Transl Med       Date:  2017-11-15       Impact factor: 17.956

2.  Gastrointestinal bleeding due to pancreatic metastasis of non-small cell lung cancer: A report of two cases and a literature review.

Authors:  Yulong Zheng; Qiqi Gao; Weijia Fang; Nong Xu; Jianying Zhou
Journal:  Oncol Lett       Date:  2015-03-12       Impact factor: 2.967

3.  The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours.

Authors:  Peter Goldstraw; John Crowley; Kari Chansky; Dorothy J Giroux; Patti A Groome; Ramon Rami-Porta; Pieter E Postmus; Valerie Rusch; Leslie Sobin
Journal:  J Thorac Oncol       Date:  2007-08       Impact factor: 15.609

Review 4.  Hemorrhage of brain metastasis from non-small cell lung cancer post gefitinib therapy: two case reports and review of the literature.

Authors:  Dan-Fang Yan; Sen-Xiang Yan; Jing-Song Yang; Yi-Xiang J Wang; Xiao-Li Sun; Xin-Biao Liao; Jun-Qing Liu
Journal:  BMC Cancer       Date:  2010-02-21       Impact factor: 4.430

5.  Exacerbated radiodermatitis and bilateral subdural hemorrhage after whole brain irradiation combined with epidermal growth factor receptor tyrosine kinase inhibitors for brain metastases in lung cancer.

Authors:  Yu-Jie Huang; Shih-Feng Liu; Chong-Jong Wang; Mei-Yueh Huang
Journal:  Lung Cancer       Date:  2007-09-04       Impact factor: 5.705

6.  Bilateral subdural hemorrhage as a possible adverse event of gefitinib in a patient with non-small cell lung cancer.

Authors:  Jung Han Kim; Hyeong Su Kim; Jong Soo Choi; Kyung Min Lee; Young Chul Shin; Byung Moo Ahn; Dae Ro Choi; Jung Hye Kwon; Sarah Park; Ho Young Kim; Joo Young Jung; Hyo Jung Kim; Hun Ho Song; Dae Young Zang
Journal:  Lung Cancer       Date:  2008-11-20       Impact factor: 5.705

7.  AZD9291 in EGFR inhibitor-resistant non-small-cell lung cancer.

Authors:  Pasi A Jänne; James Chih-Hsin Yang; Dong-Wan Kim; David Planchard; Yuichiro Ohe; Suresh S Ramalingam; Myung-Ju Ahn; Sang-We Kim; Wu-Chou Su; Leora Horn; Daniel Haggstrom; Enriqueta Felip; Joo-Hang Kim; Paul Frewer; Mireille Cantarini; Kathryn H Brown; Paul A Dickinson; Serban Ghiorghiu; Malcolm Ranson
Journal:  N Engl J Med       Date:  2015-04-30       Impact factor: 91.245

8.  Compound EGFR mutation is frequently detected with co-mutations of actionable genes and associated with poor clinical outcome in lung adenocarcinoma.

Authors:  Eun Young Kim; Eun Na Cho; Heae Surng Park; Ji Young Hong; Seri Lim; Jong Pil Youn; Seung Yong Hwang; Yoon Soo Chang
Journal:  Cancer Biol Ther       Date:  2016-01-19       Impact factor: 4.742

Review 9.  Oligometastases and oligo-recurrence: the new era of cancer therapy.

Authors:  Yuzuru Niibe; Kazushige Hayakawa
Journal:  Jpn J Clin Oncol       Date:  2010-01-04       Impact factor: 3.019

10.  Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer.

Authors:  Jean-Charles Soria; Yuichiro Ohe; Johan Vansteenkiste; Thanyanan Reungwetwattana; Busyamas Chewaskulyong; Ki Hyeong Lee; Arunee Dechaphunkul; Fumio Imamura; Naoyuki Nogami; Takayasu Kurata; Isamu Okamoto; Caicun Zhou; Byoung Chul Cho; Ying Cheng; Eun Kyung Cho; Pei Jye Voon; David Planchard; Wu-Chou Su; Jhanelle E Gray; Siow-Ming Lee; Rachel Hodge; Marcelo Marotti; Yuri Rukazenkov; Suresh S Ramalingam
Journal:  N Engl J Med       Date:  2017-11-18       Impact factor: 91.245
View more
  2 in total

1.  Intestinal Haemorrhage and Colitis Induced by Treatment With Osimertinib for Non-Small-Cell Lung Carcinoma: A Case Report.

Authors:  Wang Shujun; Lou Lili; Yang Lei; Wang Feng; Zhan Hefeng
Journal:  Front Pharmacol       Date:  2022-04-05       Impact factor: 5.810

2.  Heterochronous Metastases of Lung Adenocarcinoma to Pancreas and Liver: A Case Report from Pathological Perspectives.

Authors:  Bo Zhang; Qida Hu; Jiajie Yu; Junsen Wang; Hanjin Yang; Jiongbo Lou; Guoying Cai; Haifeng Huang; Mengqiu Xu; Zhaoying Xiao; Yun Zhang
Journal:  Onco Targets Ther       Date:  2021-07-22       Impact factor: 4.147
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.